New Agilent Target Enrichment Solution for Next-Generation DNA Sequencing Adds More Than 1,000 Disease Relevant Targets
TEVET key industry partner Agilent Technologies delivers a curated, annotated list of included genes, as well as evidence for disease relevance with SureSelect Clinical Research Exome V2—the first on the market! Researchers can discover and identify...
Read More